Actavis to buy Forest for $25 billion; windfall for investor Icahn – Reuters
New York Times |
Actavis to buy Forest for $ 25 billion; windfall for investor Icahn
Reuters (Reuters) – Generic drugmaker Actavis Plc (ACT.N) said on Tuesday it would buy Forest Laboratories Inc (FRX.N) for about $ 25 billion in cash and stock, expanding its portfolio of specialty pharmaceuticals for neurological and other disorders. The deal … Forest Laboratories pre-market shares surge on Actavis deal Actavis And Forest Labs Soaring On $ 25 Billion Deal As Carl Icahn Credits … Actavis-Forest Labs is play on changes in health care |
